comparative effectiveness

Quiz

Friday Morning Quiz: Week of September 18-24

09/22/2016

JCP Editors

A study published in the New England Journal of Medicine showed that localized prostate cancer is more likely to metastasize if patients receive which of the following treatments? radiation therapy active...

A...

09/22/2016

Journal of Clinical Pathways

Research in Review

Prostate Cancer Metastasis More Common Among Patients Receiving Active Surveillance

09/21/2016

JCP Editors

While survival at 10 years is similar, localized prostate cancer may be more likely to metastasize in men receiving active surveillance compared with those who have surgery or radiation therapy, according to results...

While...

09/21/2016

Journal of Clinical Pathways

Research in Review

Neoadjuvant Chemotherapy May Be Optimal for Stage IV Ovarian Cancer

09/15/2016

JCP Editors

Primary cytoreductive surgery (PCS) may improve survival for patients with stage III ovarian cancer, while neoadjuvant chemotherapy may be the optimal treatment for patients with stage IV disease, reported...

...

09/15/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of September 11-17

09/14/2016

JCP Editors

In a study analyzing oxygen levels within cancer tumors, researchers found that adding which of the following drugs to standard care could help to prevent the development of treatment resistance in patients with...

In a...

09/14/2016

Journal of Clinical Pathways

Research in Review

Factors Associated With Early Death Among Elderly Patients With Lymphoma

09/14/2016

JCP Editors

Administrative and cancer registry data, routinely integrated within modern electronic medical records, can help determine which patients with lymphoma are at the highest risk of dying from chemotherapy, according to...

...

09/14/2016

Journal of Clinical Pathways

Research in Review

Dose Adjustment Reduces AEs Without Impacting Efficacy in NSCLC

09/14/2016

JCP Editors

Tolerability-guided dose adjustment is an effective measure to reduce afatinib (Giotrif)-related adverse events (AEs) without affecting therapeutic efficacy in patients with non–small cell lung cancer (NSCLC),...

...

09/14/2016

Journal of Clinical Pathways

Research in Review

Little Survival Benefit from WBRT in NSCLC Patients With Brain Metastasis

09/08/2016

JCP Editors

Patients with non-small cell lung cancer and brain metastasis can be spared whole brain radiotherapy (WBRT), as it does little or has no effect on survival and quality of life, according to a study published in The...

...

09/08/2016

Journal of Clinical Pathways

Research in Review

Mayo Clinic Outlines Pathways for Thrombotic Microangiopathies

09/06/2016

JCP Editors

Members of the Mayo Clinic in Rochester, MN, have provided guidelines for the creation of evidence-based clinical pathways for thrombotic microangiopathies (TMAs). TMAs are a diverse set of disorders sharing a...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Breast Conservation Therapy at Community Settings Leads to Higher Survival Rates than the National Average

09/02/2016

JCP Editors

Breast conservation treatment may led to longer overall survival than other treatment methods for early stage breast cancer, according to a study published in The Journal of Community and Supportive Oncology....

Breast...

09/02/2016

Journal of Clinical Pathways

Research in Review

Noncompliance With NCCN Guidelines Can Worsen Rectal Cancer Survival

08/31/2016

JCP Editors

Not complying with recommendations found in National Comprehensive Cancer Network (NCCN) guidelines for locally advanced rectal cancer may led to worse overall survival, according to a study published in the journal...

Not...

08/31/2016

Journal of Clinical Pathways